Black Diamond Therapeutics, Inc.
SEC Filing List
BDTX CIK: 0001701541
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Quarterly report pursuant to Section 13 ... | Black Diamond Therapeutics, Inc. | 05/07/2026 | ||
| 8-K | Current report filing | Black Diamond Therapeutics, Inc. | 05/07/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Black Diamond Therapeutics, Inc. | Toppan Merrill/FA | 04/29/2026 | |
| DEF 14A | Definitive proxy statements | Black Diamond Therapeutics, Inc. | Toppan Merrill/FA | 04/29/2026 | |
| ARS | Annual report to security holders | Black Diamond Therapeutics, Inc. | Toppan Merrill/FA | 04/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Raman Prakash | Black Diamond Therapeutics, Inc. | 03/20/2026 | |
| 4 | Statement of changes in beneficial owner... | Behbahani Ali | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/20/2026 | |
| 8-K | Current report filing | Black Diamond Therapeutics, Inc. | 03/16/2026 | ||
| S-8 | Initial registration statement for secur... | Black Diamond Therapeutics, Inc. | Toppan Merrill/FA | 03/16/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Black Diamond Therapeutics, Inc. | 03/16/2026 | ||
| No record found. | |||||
| Load More | |||||
